Furthermore, elevated expression and activity of key metabolic genes, including hexokinase 2 (HK2), pyruvate kinase muscle 2 (PKM2) and lactate dehydrogenase A (LDHA), have been documented in various human cancers and are correlated with poorer patient survival outcomes [11, 12]. The gene discussed is LDHA; the disease is cancer.